KNSA vs AAPL: Which Stock is Better?
Side-by-side comparison of Kiniksa Pharmaceuticals Ltd and Apple Inc in 2026
KNSA
Kiniksa Pharmaceuticals Ltd
$79.81
AAPL
Apple Inc
$324.17
Key Metrics Comparison
| Metric | KNSA | AAPL | Winner |
|---|---|---|---|
| Market Cap | $3.73B | $3.83T | AAPL |
| P/E Ratio | 91.38 | 34.84 | AAPL |
| EPS (TTM) | $0.45 | $7.47 | AAPL |
| Revenue Growth | 61.2% | 7.9% | KNSA |
| Gross Margin | 0.0% | 46.9% | AAPL |
Analyze KNSA
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KNSA or AAPL a better investment?
Comparing KNSA and AAPL: Kiniksa Pharmaceuticals Ltd has a market cap of $3.73B while Apple Inc has $3.83T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KNSA and AAPL?
KNSA (Kiniksa Pharmaceuticals Ltd) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KNSA or AAPL?
Based on P/E ratios, AAPL trades at a lower multiple (34.8x vs 91.4x).
Which is growing faster: KNSA or AAPL?
KNSA has higher revenue growth at 61.2% vs 7.9% for AAPL.
Which company is more profitable: KNSA or AAPL?
Apple Inc (AAPL) has higher gross margins at 46.9% compared to 0.0% for KNSA.
Which is the larger company: KNSA or AAPL?
Apple Inc (AAPL) is larger with a market cap of $3.83T compared to $3.73B for KNSA.
Should I buy KNSA or AAPL in 2026?
Both KNSA and AAPL have investment merit. KNSA trades at $79.81 while AAPL trades at $324.17. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KNSA and AAPL stock?
Key differences: Market Cap ($3.73B vs $3.83T), P/E Ratio (91.4x vs 34.8x), Revenue Growth (61.2% vs 7.9%), Gross Margin (0.0% vs 46.9%).
Should I buy KNSA or AAPL in 2026?
The choice between KNSA and AAPL depends on your investment goals. KNSA shows higher revenue growth (61.2%). AAPL has better margins (46.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between KNSA and AAPL?
KNSA (Kiniksa Pharmaceuticals Ltd) has a market cap of $3.73B, while AAPL (Apple Inc) has a market cap of $3.83T. AAPL is the larger company by market value.